Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for Syndax Pharmaceuticals Inc, €490k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Botwood Nicholas A.J.: trading record in brief
Botwood Nicholas A.J. discloses dealings in Syndax Pharmaceuticals Inc to SEC (Form 4). In total, 2 filings cover trades dated from 11 June 2026 to 12 June 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 12 June 2026, reports a transaction of €490k in Syndax Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Botwood Nicholas A.J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
31,235 shares@ US$18.14290.035% mcap44.1% of flowCommonSEC144:0001959173-26-004618
34,280 shares@ US$17.77810.037% mcap47.4% of flowCommonSEC144:0001959173-26-004566
2 of 2 declarations
